Search

everythinglearnresearchcommunity

for

Search:↓

Nanotechnology is improving drug delivery and targeting, with promising applications in cancer treatment, gene therapy, and cosmetics, but challenges remain in ensuring precise delivery and safety.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Dermatology drug use in Denmark mostly follows expected patterns, but further checks are needed for any misuse.

The Exfoliate-Dissolve-Repair skincare approach may effectively treat keratosis pilaris and reduce the need for corticosteroids.

The FDA did not approve certain drugs for prostate cancer prevention due to concerns about their effectiveness and potential risks.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

Hair disorders in organ transplant patients are often underestimated and need more attention and research.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

Symptom experience doesn't affect medication compliance in liver transplant patients.

CUR-loaded micelles improve skin delivery and effects of curcumin for pain and infections.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

Early diagnosis, innovative treatments, and considering systemic conditions are crucial in dermatological care.

Finasteride dosages should be adjusted based on CYP3A5 genotype and liver function to avoid side effects.

Both microneedling and injections are equally effective for treating alopecia areata.

Kidney transplant patients who had COVID-19 experienced a significant drop in their quality of life due to long-lasting symptoms.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Mycophenolate mofetil effectively improved skin pigmentation and itching in a woman with lichen planus pigmentosus and frontal fibrosing alopecia.

Regulating cell death in hair follicles can help prevent hair loss and promote hair growth.

Chronic burn scars may lead to scalp skin issues, so doctors should consider this when diagnosing.

Nanoemulgels could effectively treat skin diseases and may replace or complement current therapies.

The study found key factors in the cause of hidradenitis suppurativa, its link to other diseases, and identified existing drugs that could potentially treat it.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Microneedles in wearables can deliver drugs over time but face challenges in manufacturing and safety.